Goldman Sachs upgrades Accretive Health (AH) to Buy from Neutral with a price target of $31....

|About: Accretive Health, Inc. (ACHI)|By:, SA News Editor

Goldman Sachs upgrades Accretive Health (AH) to Buy from Neutral with a price target of $31. Analysts with the firm think investors will become comfortable with the temporary "growing pains" seen by Accretive Health that has dented the share price. "We believe focus will shift back to the key driver of growth."